NVIDIA disclosed planned investments in Doctolib, Entalpic, Genesis AI and Pigment on October 13, 2026, expanding its commitments in France's AI ecosystem across healthcare, materials discovery, robotics and enterprise software.
NVIDIA announced planned investments in four French startups on October 13, 2026, according to a company blog post by Nat Ives. The investments target Doctolib, Entalpic, Genesis AI and Pigment, expanding NVIDIA's commitments in France across healthcare, materials discovery, robotics and enterprise software. The announcement did not disclose investment amounts or terms.
According to the October 13 blog post, NVIDIA has previously invested in French technology companies including Alice&Bob, Gradium and Scintil Photonics. The company stated it has committed nearly $10 billion to the technology ecosystem across all of Europe, though the blog post does not break out France-specific totals or distinguish equity investments from infrastructure partnerships and non-equity support programs.
Doctolib is a European healthcare technology company that builds agents to support healthcare professionals and provide patients with digital health tools, according to the October 13 announcement. The company focuses on improving care access and supporting preventive medicine.
Entalpic, a Paris-based startup, accelerates the engineering of advanced materials at the atomic scale, with expertise in surfaces and interfaces for semiconductor manufacturing and next-generation electronics, the announcement stated.
Genesis AI is a global robotics company developing general-purpose robots through foundation models, data collection systems, simulation infrastructure and robot hardware, NVIDIA reported.
Pigment, a Paris-based enterprise software company, builds a planning platform that helps businesses forecast performance, model scenarios and make decisions across finance, sales, workforce and operations, according to the blog post.
Source link
